Related Experiment Videos

Receptor and centriole pathways of steroid action in normal and neoplastic cells

Cancer Research
|November 1, 1978
PubMed

Insights

Estradiol receptor defects in human breast cancer cells may explain unresponsiveness to endocrine therapy. Steroids may also regulate cell proliferation via centriole activity.

Area of Science:

  • Endocrinology
  • Cell Biology
  • Oncology

Background:

  • Estradiol receptor (ER) function is critical in hormone-dependent cancers.
  • Dysregulation of ER signaling is implicated in endocrine therapy resistance.
  • Steroid hormones play roles in various cellular processes beyond classical receptor pathways.

Purpose of the Study:

  • To investigate estradiol kinetics and receptor defects in human breast cancer.
  • To explore the role of steroids in centriole activity and cell proliferation.

Main Methods:

  • Utilized an experimental system for tracing estradiol kinetics using specific antibodies.
  • Applied UV and electron microscopy to visualize immunoreactive steroids and receptor complexes.
  • Analyzed receptor presence, nuclear transfer, and retention in breast cancer cells.

Main Results:

  • Identified major defects in the estradiol receptor mechanism in human breast cancer.
  • Observed lack of cytoplasmic receptors, impaired nuclear transfer, and abnormal nuclear retention of estradiol:receptor complexes.
  • Demonstrated steroid presence in pericentriolar material correlating with centriole activity and cell cycle modulation.

Conclusions:

  • Estradiol receptor abnormalities may underlie breast cancer's unresponsiveness to endocrine management.
  • A novel centriole pathway for steroid hormone regulation of cell proliferation is proposed.
  • Findings suggest a broader role for steroids in cell cycle control and cancer progression.

Related Concept Videos